iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
174.85
+0.97 (0.56%)
Feb 27, 2026, 3:21 PM EST - Market open
IBB Holdings Information
IBB is an equity ETF with a total of 262 individual holdings. The top holdings are Gilead Sciences stock at 9.31%, Vertex Pharmaceuticals at 8.87%, Amgen at 8.86%, Regeneron Pharmaceuticals at 6.75%, and Alnylam Pharmaceuticals at 3.61%.
Total Holdings
262
Top 10 Percentage
49.77%
Asset Class
Equity
ETF Category
Health
Assets
8.65B
PE Ratio
24.67
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 9.31% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 8.87% |
| 3 | AMGN | Amgen Inc. | 8.86% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.75% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.61% |
| 6 | ARGX | argenx SE | 2.81% |
| 7 | INSM | Insmed Incorporated | 2.66% |
| 8 | BIIB | Biogen Inc. | 2.38% |
| 9 | NTRA | Natera, Inc. | 2.37% |
| 10 | ONC | BeOne Medicines AG | 2.17% |
| 11 | UTHR | United Therapeutics Corporation | 1.89% |
| 12 | INCY | Incyte Corporation | 1.65% |
| 13 | ILMN | Illumina, Inc. | 1.54% |
| 14 | MRNA | Moderna, Inc. | 1.51% |
| 15 | RVMD | Revolution Medicines, Inc. | 1.45% |
| 16 | GMAB | Genmab A/S | 1.22% |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 1.09% |
| 18 | NBIX | Neurocrine Biosciences, Inc. | 1.08% |
| 19 | ROIV | Roivant Sciences Ltd. | 1.05% |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 0.99% |
| 21 | EXEL | Exelixis, Inc. | 0.99% |
| 22 | BBIO | BridgeBio Pharma, Inc. | 0.93% |
| 23 | ASND | Ascendis Pharma A/S | 0.90% |
| 24 | RNA | AVIDITY BIOSCIENCES INC | 0.85% |
| 25 | MEDP | Medpace Holdings, Inc. | 0.84% |
As of Feb 25, 2026